研究文章

Sestrin2通过激活AMPK并抑制mTOR通路减轻脓毒症肝损伤的保护作用机制研究

摘要

目的:本研究探究Sestrin2在脓毒症相关肝损伤(sepsis-associated liver injury,SALI)中的作用,为SALI靶向干预提供理论依据。方法:采用脂多糖(lipopolysaccharide , LPS)刺激大鼠BRL-3A肝细胞建立体外SALI模型,将细胞分为Ctrl组、LPS组、LPS+NC siRNA组、LPS+siSestrin2组,通过siRNA转染敲低Sestrin2表达。采用RT-qPCR检测炎症因子IL-6、IL-1β、TNF-α的mRNA表达,Reitman-Frankel法检测肝损伤标志物丙氨酸氨基转移酶(Alanine Aminotransferase,ALT)、天冬氨酸氨基转移酶(Aspartate Aminotransferase, AST)活性,结合Western blot与RT-qPCR检测Sestrin2的表达水平。结果:LPS可显著诱导肝细胞炎症反应与肝损伤,成功构建SALI模型,且模型中Sestrin2表达显著上调。敲低Sestrin2后,LPS介导的肝细胞损伤明显加重,促炎因子mRNA表达水平显著升高。结论:Sestrin2参与SALI的发生发展,从而抑制炎症反应

关键词

脓毒症肝损伤;Sestrin2;炎症反应

参考

Singer M, Deutschman C S, Seymour C W, et al. The Thi-rd International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801.

Zhang J B, Zhang Q R, Jin Q, et al. Sestrin2 maintains he-patic immune homeostasis and redox balance partially viainhibiting RIPK3-mediated necroptosis in metabolic dysf-unction-associated steatohepatitis[J]. Molecular Metabolis-m, 2024, 80: 101865.

Budanov A V, Karin M. p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling[J].Cell, 2008, 134(3): 451-460.

Raetz C R H, Whitfield C. Lipopolysaccharide Endotoxins-[J]. Annual Review of Biochemistry, 2002, 71(1): 635-70-0.

何翠霞, 朱敏慧, 徐媛媛, 等. 跨膜蛋白 TMEM88 在LPS/D-GaIN 诱导的急性肝损伤中的作用[J]. 中华全科医学, 2024, 22(5): 786-790.

Zhang X, Yuan S, Fan H, et al. Liensinine alleviates seps-is-induced acute liver injury by inhibiting the NF-κB andMAPK pathways in an Nrf2-dependent manner[J]. Chemico-Biological Interactions, 2024, 396: 111030.

脂多糖对BRL大鼠肝细胞的损伤研究-黄敏聪.pdf[Z].

Chousterman B G, Swirski F K, Weber G F. Cytokine sto-rm and sepsis disease pathogenesis[J]. Seminars in Immu-nopathology, 2017, 39(5): 517-528.

Davies S P, Terry L V, Wilkinson A L, et al. Cell-in-Cell Structures in the Liver: A Tale of Four E’s[J]. Frontiers in Immunology, 2020, 11: 650.

Imaeda A B, Watanabe A, Sohail M A, et al. Acetaminop-hen-induced hepatotoxicity in mice is dependent on Tlr9and the Nalp3 inflammasome[J]. Journal of Clinical Inv-estigation, 2009: JCI35958.

Protzer U, Maini M K, Knolle P A. Living in the liver:hepatic infections[J]. Nature Reviews Immunology, 201-2, 12(3): 201-213.

Liu Y, Hu S, Shi B, et al. The Role of Iron Metabolismin Sepsis-associated Encephalopathy: a Potential Target[-J]. Molecular Neurobiology, 2024, 61(7): 4677-4690.

Zhang Y, Wu F, Teng F, et al. Deficiency of S100A9 Al-leviates Sepsis-Induced Acute Liver Injury through Reg-ulating AKT-AMPK-Dependent Mitochondrial Energy Metabolism[J]. International Journal of Molecular Science-s, 2023, 24(3): 2112.

Xu X, Yang T, An J, et al. Liver injury in sepsis: manife-stations, mechanisms and emerging therapeutic strategies-[J]. Frontiers in Immunology, 2025, 16: 1575554.

Lu C, Jiang Y, Xu W, et al. Sestrin2: multifaceted functi-ons, molecular basis, and its implications in liver diseas-es[J]. Cell Death & Disease, 2023, 14(2): 160.

Wang L X, Zhu X M, Yao Y M. Sestrin2: Its Potential Role and Regulatory Mechanism in Host Immune Responsein Diseases[J]. Frontiers in Immunology, 2019, 10: 2797.

Han D, Kim H, Kim S, et al. Sestrin2 protects against cholestatic liver injury by inhibiting endoplasmic reticulumstress and NLRP3 inflammasome-mediated pyroptosis[J].Experimental & Molecular Medicine, 2022, 54(3): 239-2-51.27

Refbacks

  • 当前没有refback。
版权所有(c)2026 曦丹 胡, 志方 郑, 祎 刘, 益婷 丁, 小青 敬
Creative Commons License
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。